Chiome Bioscience Balance Sheet

Financials in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	1,142	1,205	2,063	1,326	1,727	1,791
Cash & Short-Term Investments	1,142	1,205	2,063	1,326	1,727	1,791
Cash Growth	-37.24%	-41.60%	55.65%	-23.26%	-3.56%	-33.33%
Accounts Receivable	55.52	72	51.06	83.19	115.22	25.46
Other Receivables	6.02	29.52	24.43	25.05	29.57	36.05
Receivables	61.54	101.52	75.49	108.24	144.79	61.51
Inventory	44.74	49.41	46.17	64.11	71.48	59.05
Prepaid Expenses	-	55.04	46.66	43.85	57.15	34.47
Other Current Assets	244.84	135.71	106.08	87.65	91.48	270.87
Total Current Assets	1,493	1,547	2,338	1,629	2,092	2,217
Property, Plant & Equipment	36.68	36.34	-	1.17	2.44	4.2
Other Long-Term Assets	140.9	144.47	131.19	120.89	120.87	118.36
Total Assets	1,670	1,728	2,469	1,751	2,215	2,339
Accounts Payable	34.74	37.44	27.2	37.74	31.87	29.81
Accrued Expenses	10.99	14.56	29.56	32.32	32.91	44.46
Short-Term Debt	86.7	86.7	281.5	291	184	183
Current Income Taxes Payable	5.79	12.55	2.53	23.95	23.94	16.75
Current Unearned Revenue	96.44	130.33	-	-	-	-
Other Current Liabilities	67.9	93.31	152.65	154.03	97.74	118.53
Total Current Liabilities	302.56	374.89	493.43	539.04	370.46	392.54
Other Long-Term Liabilities	55.66	230.56	55.12	54.69	54.27	53.85
Total Liabilities	358.22	605.44	548.55	593.73	424.72	446.39
Common Stock	1,299	1,086	995.53	2,388	2,097	1,516
Retained Earnings	2.94	22.24	915.02	-1,248	-319.53	342.02
Treasury Stock	-0.3	-0.29	-0.29	-0.29	-0.29	-0.29
Comprehensive Income & Other	9.97	14.59	10.05	17.74	13.55	35.4
Total Common Equity	1,312	1,122	1,920	1,158	1,791	1,893
Shareholders' Equity	1,312	1,122	1,920	1,158	1,791	1,893
Total Liabilities & Equity	1,670	1,728	2,469	1,751	2,215	2,339
Total Debt	86.7	86.7	281.5	291	184	183
Net Cash (Debt)	1,055	1,118	1,782	1,035	1,543	1,608
Net Cash Growth	-31.38%	-37.23%	72.23%	-32.96%	-4.03%	-35.84%
Net Cash Per Share	15.38	16.47	30.61	20.88	35.09	39.92
Filing Date Shares Outstanding	72.63	68.44	66.96	52.63	48.42	40.78
Total Common Shares Outstanding	72.63	68.44	66.96	52.63	48.42	40.78
Working Capital	1,190	1,172	1,844	1,090	1,722	1,824
Book Value Per Share	18.06	16.39	28.68	22.00	36.98	46.42
Tangible Book Value	1,312	1,122	1,920	1,158	1,791	1,893
Tangible Book Value Per Share	18.06	16.39	28.68	22.00	36.98	46.42
Machinery	332.07	329.98	312.86	318.96	351.63	387.39